CAS: 33414-33-4 - 2-(Ethoxycarbonylamino)-10-[3-(diethylamino)propionyl]phenothiazine
Formula:C22H27N3O3S
InChI:InChI=1S/C22H27N3O3S/c1-4-24(5-2)14-13-21(26)25-17-9-7-8-10-19(17)29-20-12-11-16(15-18(20)25)23-22(27)28-6-3/h7-12,15H,4-6,13-14H2,1-3H3,(H,23,27)
InChI key:InChIKey=PQXGNJKJMFUPPM-UHFFFAOYSA-N
SMILES:O=C(OCC)NC1=CC=C2SC=3C=CC=CC3N(C(=O)CCN(CC)CC)C2=C1
- Synonyms:
- Carbamic acid, N-[10-[3-(diethylamino)-1-oxopropyl]-10H-phenothiazin-2-yl]-, ethyl ester
- Carbamic acid, [10-[3-(diethylamino)-1-oxopropyl]-10H-phenothiazin-2-yl]-, ethyl ester
- Etacizin
- Ethacizin
- Ethacizine
- Ethacyzin
- Ethmozine DAA
- Ethyl N-[10-[3-(diethylamino)-1-oxopropyl]-10H-phenothiazin-2-yl]carbamate
- Etmozine DAA
- Ez 55
- See more synonyms
- NSC 621878
- Nik-244
- Phenothiazine-2-carbamic acid, 10-(N,N-diethyl-β-alanyl)-, ethyl ester
- [10-(3-Diethylamino-propionyl)-10H-phenothiazin-2-yl]-carbamic acid ethyl ester
- [10-[3-(Diethylamino)-1-oxopropyl]-10H-phenothiazin-2-yl]carbamic acid ethyl ester
- ethyl [10-(N,N-diethyl-beta-alanyl)-10H-phenothiazin-2-yl]carbamate
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Ethacizine REF: 4Z-M-241006CAS: 33414-33-4 | - - - | To inquire | Wed 08 Jan 25 | |
Ethacizine-d10 REF: 4Z-M-241007CAS: 33414-33-4 | - - - | To inquire | Wed 08 Jan 25 | |
Ethacizine REF: 3D-FE179452CAS: 33414-33-4 | Min. 95% | To inquire | Tue 14 Jan 25 |
Ref: 4Z-M-241006
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 8 Jan 2025
Ref: 4Z-M-241007
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 8 Jan 2025
Ethacizine
CAS:33414-33-4
Ethacizine is a cardiac drug that belongs to the group of beta-adrenergic blocking agents. It …
Formula:
C22H27N3O3S
Purity:
Min. 95%
Molecular weight:
413.53 g/mol
Ref: 3D-FE179452
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025